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INTRODUCTION
Acute ischaemic stroke (AIS) is one of the leading 
causes of mortality and long-term disability worldwide. 
Intravenous tissue plasminogen activator (IV rtPA) 
is an approved treatment for AIS, though many 
patients will not qualify for the treatment because of 
the narrow time window for administration of rtPA. 
Recently, endovascular treatment with mechanical 
thrombectomy has been shown to yield superior 
outcomes than pharmacological management alone 
for AIS affecting the anterior circulation.[1-5]
The anaesthetic management of patients undergoing 
mechanical thrombectomy varies between general 
anaesthesia (GA) with or without intubation, conscious 
sedation (CS), to completely awake patients under 
local anaesthesia. Multiple studies have compared GA 
and CS for the endovascular treatment of AIS and have 
reported an association of GA with poor outcomes.[6-14] 
In most of these studies, patients who received GA 
had a higher pre-procedural NIHSS score and required 
intubation for airway protection. In these studies, GA 
was found to be an independent predictor for poor 
outcomes even after adjusting for stroke severity, 
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ABSTRACT
Background and Aims: Though, many practitioners prefer conscious sedation (CS), it is unclear 
which factors most influence neurological outcome following mechanical thrombectomy under 
CS. The aim of this retrospective study is to identify these factors. Methods: After institutional 
review board approval, data were collected for the patients >18 years of age who underwent 
endovascular treatment of AIS under CS at our comprehensive stroke centre between January 
2009 and June 2015. The primary outcome measure was the modified Rankin Scale (mRS) at 
discharge. A good outcome was defined as mRS 0–3 and poor outcome as mRS 4–6. Univariate 
and logistic regression analysis were performed to identify the independent predictors of poor 
outcomes at discharge. A P < 0.05 was considered statistically significant. Results: One hundred 
two patients, aged 67 ± 16 years were included. The anterior cerebral circulation was affected 
in 88 patients (86%), and the median National Institute of Health Stroke Scale (NIHSS) score 
at presentation was 17.5 (range: 1–36). Overall, 21 (21%) patients had good outcome and 
81 (79%) had poor outcome. Logistic regression identified the modified treatment in cerebral 
ischaemia (mTICI) score [odds ratio (OR): 0.443, confidence interval (CI): 0.244–0.805], 
NIHSS score (OR: 1.290, CI: 1.125–1.481) and previous transient ischaemic attack (TIA) (OR: 
6.988, CI: 1.342–36.380) as significant independent predictors of poor outcome at discharge. 
Conclusion: The outcome of patients who underwent endovascular treatment of AIS under CS 
depends on the mTICI score, NIHSS score and history of previous TIA.
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though the reasons are not clear. It is speculated that 
the variation in the haemodynamic changes occurring 
during GA, mainly hypotension and hypocapnia, 
might lead to poorer outcomes.[14,15] Based on these 
studies, CS has become a popular anaesthetic choice 
for mechanical thrombectomy. It is unclear, however, 
which factors under CS anaesthesia influence clinical 
outcome. The aim of this retrospective study is to 
identify these factors.
METHODS
The institutional review board (IRB) approval was 
obtained to conduct this retrospective chart review 
of patients treated at a single hospital between 
January 2009 and June 2015. Patients 18 years old 
or older who underwent endovascular treatment 
for AIS under CS were included. Patients treated 
under GA were excluded. CS with midazolam and 
fentanyl titrated to the Richmond Agitation-Sedation 
Scale	 0	 to	 −3	 was	 provided	 by	 trained	 nursing	
staff in neurointerventional radiology. Mechanical 
thrombectomies were done by one of the three 
fellowship-trained interventional neuroradiologists. 
Anaesthetic details and the vital signs during the 
procedure were collected from the paper chart. 
Comorbid diseases, medication history, laboratory 
parameters and social history were collected from the 
electronic medical record. The National Institute of 
Health Stroke Scale (NIHSS) score and the modified 
Rankin Score (mRS) at discharge were obtained from 
a stroke neurology database. Modified treatment in 
cerebral ischaemia (mTICI) scores, stroke territory, 
devices used for the procedure and post-procedure 
haemorrhagic complications were collected from a 
radiology database. NIHSS score was evaluated by 
vascular neurology residents and fellows, mTICI score 
was evaluated by interventional neuroradiologist and 
mRS score was evaluated by stroke nurses certified in 
the use of the mRS instrument. The primary outcome 
measure is the mRS at discharge. Good outcome is 
defined as mRS 0–3 and poor outcome as mRS 4–6.
Statistical analysis
Statistical analysis was performed with the SAS 
version 9.4 (SAS Institute, Cary, North Carolina). 
The clinical, anaesthetic, haemodynamic and 
neurointerventional characteristics of patients with 
poor outcome were compared to those patients 
with good outcome using univariate statistics, 
specifically the Chi-square test, Fisher exact test and 
independent t-test. Variables which were tested to be 
not normally distributed were represented as median 
and interquartile range (IQR). All factors that were 
statistically significant (P < 0.05) in the univariate 
analysis were entered into a combination of forward 
and backward stepwise modelling techniques. The 
stepwise procedure in each specification technique 
was designed to construct a model that can best explain 
the multivariable relationships in the data. At each 
modelling step, a factor may be automatically added 
or removed based on its contribution to the overall 
model fit and its own significance level (P < 0.05). The 
final forward and backward models included slightly 
different subsets of significant factors. These selected 
factors were then combined into a final regression 
and rerun to reconcile between the two technical 
approaches and presented as the best-fitting model. 
The overall fit of the final model was assessed using 
the c-statistic, measuring the area under the receiver 
operating characteristic (ROC) curve and the Hosmer 
and Lemeshow test as a measure of goodness of fit. 
A model parameter with P < 0.05 was considered 
statistically significant.
RESULTS
A total of 102 patients with mean age 67 ± 16 years 
were included in the study. Eighty-eight (86%) of the 
patients were affected by anterior circulation stroke. 
The median pre-procedural NIHSS was 17.5 ranging 
from (1–36). Overall 21 (21%) patients had good 
outcome at discharge. Penumbra, Solitaire, Merci and 
Trevo devices were each used at least once during the 
study period. Fifty-five (54%) patients had mechanical 
thrombectomy alone without IV rtPA, 37 (36%) received 
intravenous tPA and mechanical thrombectomy, 
5 (5%) received intra-arterial tPA, 2 (2%) received 
intra-arterial tPA and mechanical thrombectomy, 
2 (2%) received mechanical thrombectomy and 
angioplasty and 1 (1%) received intravenous tPA, 
mechanical thrombectomy and intra-arterial tPA.
Table 1 shows the clinical and neurointerventional 
characteristics for both the groups at discharge. 
Twenty (25%) patients in the poor outcome group had 
post-procedure haemorrhagic complications compared 
with 0 (0%) in patients with good outcome (P = 0.01). 
About 38 (47%) patients with poor outcome had 
previous transient ischaemic attack (TIA) compared 
to 3 (14%) in patients with good outcome (P = 0.006). 
There was no appreciable difference in outcome based 
on the type of devices used during the procedure, 
comorbid illnesses (hypertension, diabetes mellitus, 
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renal insufficiency, congestive heart failure, coronary 
artery disease, atrial fibrillation and hyperlipidaemia), 
smoking history or use of medications.
Table 2 shows the clinical, neurointerventional, 
laboratory and anaesthetic characteristics for both 
the groups at discharge. mTICI scoring after the 
intervention was lower (P = 0.01) and the NIHSS score 
was higher (P	≤	0.0001)	 in	 the	poor	 outcome	group	
compared to the good outcome group. Average systolic 
blood pressure (SBP) and diastolic blood pressure were 
significantly different between both the groups, with 
higher values in the poor outcome group (P = 0.013, 
0.005). There was no difference in outcome based 
on age, laboratory parameters [glucose, high-density 
lipoprotein (HDL), low-density lipoprotein (LDL), 
HbA1c and creatinine levels] or the amount of 
anaesthetic agent used during the procedure.
Logistic regression was performed to identify 
independent factors associated with poor outcome at 
discharge [Table 3]. All predictor variables selected 
Table 1: Clinical and neurointerventional characteristics by discharge outcome. Categorical variables are represented as 
number (percent) 
Characteristic Overall n (%) Good outcome (mRS 0‑3) (n=21) Poor outcome (mRS 4‑6) (n=81) P
Anterior circulation n (%) 88 (86%) 21 (100%) 67 (83%) 0.07
Aspiration device n (%) 29 (28%) 5 (24%) 24 (30%) 0.59
Retriever device n (%) 29 (28%) 6 (29%) 23 (28%) 0.98
Retriever and aspiration device n (%) 33 (32%) 6 (29%) 27 (33%) 0.67
Post‑procedure haemorrhage on CT n (%) 20 (20%) 0 (0%) 20 (25%) 0.01
Hypertension n (%) 77 (75%) 13 (62%) 64 (79%) 0.1
Diabetes n (%) 31 (30%) 6 (29%) 25 (31%) 0.84
Hyperlipidaemia n (%) 46 (45%) 10 (48%) 36 (44%) 0.79
Renal insufficiency n (%) 17 (17%) 3 (14%) 14 (17%) 1.0
CAD/MI n (%) 28 (27%) 6 (29%) 22 (27%) 0.89
Congestive heart failure n (%) 18 (18%) 3 (14%) 15 (19%) 0.75
Cardiomyopathy n (%) 14 (14%) 2 (10%) 12 (15%) 0.72
Atrial fibrillation n (%) 31 (30%) 6 (29%) 25 (31%) 0.83
Previous TIA n (%) 41 (40%) 3 (14%) 38 (47%) 0.006
Smoking n (%) 20 (20%) 2 (10%) 18 (22%) 0.23
P<0.05 is statistically significant. mRS – Modified Rankin scale; CAD – Coronary artery disease; MI – Myocardial infarction; TIA – Transient ischaemic attack
Table 2: Clinical, neurointerventional, laboratory and anaesthetic characteristics by discharge outcome. Normally 
distributed continuous variables are represented as mean±standard deviation and others are represented as median/
interquartile range
Characteristic Overall (mean±SD)/
(median/IQR)
Good outcome 
(mRS 0‑3) (n=21)
Poor outcome 
(mRS 4‑6) (n=81)
P
Age (mean±SD) 66.72±16 68±14 66±17 0.62
mTICI score (median/IQR) 3/2‑4 4/3‑4 3/2‑4 0.01
Pre‑procedural NIHSS score (mean±SD) 18.26±6.76 12.42±5.48 19.8±6.2 <0.0001
HbA1c (median/IQR) 6/5.6‑6.5 5.9/5.6‑6 6.1/5.7‑6.6 0.1
Creatinine (median/IQR) 0.96/.78‑1.17 1.07/0.74‑1.13 0.95/0.79‑1.2 0.97
Troponin (median/IQR) 0.07/0.03‑0.07 0.03/0.03‑0.07 0.07/0.03‑0.07 0.16
Blood glucose (mean±SD) 138.32±43.56 131.3±52.75 140.2±40.89 0.4
Average RASS (mean±SD) −1.79±1.57 −1.28±0.90 −1.92±1.68 0.02
Average FiO2 (mean±SD) 0.46±0.25 0.35±0.15 0.48±0.26 0.005
Average SpO2 (mean±SD) 97.89±1.72 97.90±1.57 97.88±1.76 0.97
Average SBP (mean±SD) 140.47±20.14 130.9±17.03 143±20.22 0.013
Average DBP (mean±SD) 76.60±13.43 69.47±14.14 78.44±12.68 0.005
Average HR (mean±SD) 81.73±17.47 74.19±18.46 83.67±16.77 0.02
Average RR (mean±SD) 17.87±3.88 17.47±4.33 17.97±3.77 0.6
Midazolam (mg) (median/IQR) 1/0‑2 1/.5‑3.5 0.63/0‑2 0.18
Fentanyl (mcg) (mean±SD) 105.51±93.42 108.3±104.1 104.8±91.14 0.8
LDL (median/IQR) 83/61‑111 81/73‑102.5 84/57‑116 0.62
HDL (mean±SD) 45.06±13.74 46.4±9.06 44.66±14.85 0.52
P<0.05 is statistically significant. NIHSS – National Institute of Health Stroke Scale; mTICI – modified treatment in cerebral ischaemia; mRS – Modified Rankin 
scale; LDL – Low‑density lipoprotein; HDL – High‑density lipoprotein; RASS – Richmond Agitation‑Sedation scale; SBP – Systolic blood pressure; DBP – Diastolic 
blood pressure; HR – Heart rate; RR – Respiratory rate; FiO2 – Fraction of inspired oxygen; SpO2 – Oxygen saturation; HbA1c – Glycosylated haemoglobin
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for these procedures, GA cannot be avoidable 
in certain group of patients such as those with 
posterior circulation stroke or those who are highly 
uncooperative or agitated.
Studies which compared GA and CS during 
endovascular treatment of AIS have favoured CS 
based on superior outcomes,[6-14] though a recent 
prospective, randomised trial found no difference in 
outcomes between the GA and CS groups.[16] Those 
studies which did suggest superior outcomes with 
CS speculated that the haemodynamic parameters 
such as hypocapnia and hypotension may lead to 
poor outcomes under GA[14,15] and thus recommend 
the maintenance of normocapnia (35–45 mmHg) and 
SBP in the range of 140–180 mmHg.[17] In our study, 
we found no evidence of difficulty maintaining SBP 
in these patients. Indeed, most of these patients were 
hypertensive at presentation and several needed 
antihypertensive agents to lower intraprocedural SBP. 
It is surprising to note that higher blood pressures 
were associated with worse outcomes in this study. 
This may be related to more severe strokes or lower 
recanalisation rates. However, this factor was not 
significant in the multivariable analysis.
Excessive mechanical ventilation under GA can result 
in hypocapnia, which in turn may lead to cerebral 
vasoconstriction and exacerbate poor outcome in the 
setting of AIS. It is assumed that patients under CS 
with spontaneous ventilation maintain normocapnia, 
which might avoid the possibility of cerebral 
vasoconstriction and yield better clinical outcomes. In 
using the stepwise procedure were entered into 
the final model as a single step rather than filtering 
independent variables based on their final significant 
P values. The final multivariable logistic regression 
model had a very good discrimination (c-statistic of 
0.89) and a good calibration (Hosmer–Lemeshow test, 
Chi-square = 4.0193, P = 0.8554) with an overall area 
under the curve 0.89 [Figure 1]. The mTICI scoring 
[odds ratio (OR): 0.443, confidence interval (CI): 
0.244–0.805] (P = 0.007), NIHSS score (OR: 1.290, 
CI: 1.125–1.481) (P = 0.0003) and TIA (OR: 6.988, 
CI: 1.342–36.380) (P = 0.02) were found to be the 
significant predictors of poor outcome at discharge.
DISCUSSION
Our study finds that the outcome of the patients at 
discharge who underwent endovascular treatment for 
AIS under CS is mainly dependent on 1) NIHSS score 
at presentation 2) post-treatment mTICI score and 3) a 
history of previous TIA. To the best of our knowledge, 
this is the first study which compared the outcomes 
under CS for the endovascular treatment of AIS. 
Though CS is a recommended choice when feasible 
Table 3: Final logistic regression analysis for poor 
outcome at discharge
Characteristic Odds ratio 95% Confidence interval P
mTICI score 0.443 0.244‑0.805 0.007
NIHSS score 1.290 1.125‑1.481 0.0003
TIA 6.988 1.342‑36.380 0.02
P<0.05 is statistically significant mTICI – Modified treatment in cerebral 
ischaemia score; NIHSS – National Institute of Health Stroke Scale; 
TIA – Transient ischaemic attack
Figure 1: Shows the receiver operating characteristic curve for the predictor variables and the entire model. Area under the curve for the overall 
model is 0.8903
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our study, we are not able to determine the effect of CO2 
level as arterial lines were not placed for most patients. 
Furthermore, end-tidal CO2 (EtCO2) measurements 
from the nasal cannula or the non-rebreather simple 
oxygen mask used during CS are only indicative of 
adequate ventilation and do not accurately quantify 
CO2.
Our finding of the association of higher NIHSS 
score and the poor outcomes in these patients 
is not surprising. NIHSS score is known to be a 
strong predictor of functional outcome after AIS 
[Appendix 1].[18,19] TICI score is the most widely 
accepted scale to assess the extent of reperfusion 
after the mechanical thrombectomy and has a 
proven value for predicting clinical outcome after 
AIS [Appendix 2].[20,21] As expected, we found an 
association between poor outcome at discharge and 
lower mTICI score. Another significant finding in our 
study is that previous TIA is independently associated 
with poor outcome. The existing literature on this 
association is mixed. Some authors have suggested 
that a history of TIA confers neuroprotection due 
to ischaemic preconditioning, resulting in better 
outcomes following AIS in patients with a history of 
previous TIA.[22-24] Others, like us, have suggested that 
previous TIA leads to poor outcome.[25] Additional 
factors such as the subtype of stroke or the duration, 
location and timing of previous TIA might influence 
the association between these factors.
The overall outcomes in this cohort were worse than 
those reported in the recent thrombectomy trials.[26,27] 
This is likely related to several factors. Many of these 
patients were treated with older generation devices 
with lower recanalisation rates. In addition, patient 
selection was generally based on the presence of 
a large vessel occlusion, onset within 6 h and the 
absence of extensive early ischaemic changes on CT. 
These inclusion criteria are similar to those used in 
MR CLEAN[7] and these outcomes are similar.
Our study has several limitations. First, this is a single 
centre retrospective study with associated risk of bias. 
Second, sample size is relatively small due to the lack 
of widespread adoption of mechanical thrombectomy 
prior to the publication of positive trials, and therefore 
this study is likely underpowered to eliminate 
all clinically important associations between the 
anaesthetic factors and the neurologic outcomes. 
Third, some data are not universally available or of 
desired quality. For example, onset-to-reperfusion 
time and initial SBP are generally unavailable in 
patients transferred from outside hospitals, while 
EtCO2 PaCO2 were not measured in all patients, and 
intra-procedural blood pressures were recorded only 
every 10 min. Fourth, CS is generally administered 
by the neurointerventional team rather than by 
anaesthesiologists. Fifth, variations in treatment 
methods, including specific device used, may have 
influenced outcomes. Sixth, our classification and 
analysis of the mRS (0–2) as good outcomes resulted 
in a questionable validity of our model because of 
smaller sample size. Most clinicians agree that a 
mRS 0–2 reflects better the reality of a good outcome. 
However, there are other articles which have taken 
mRS (0–3) as good outcomes based on the functional 
independence [Appendix 3].[28,29] Finally, the method 
of patient selection in the early part of the review 
period may not reflect current practices. At our 
hospital, for instance, thrombectomy was considered 
experimental prior to publication of positive 
thrombectomy trials and was generally performed 
only for profoundly affected patients that did not 
qualify for other treatments, which likely skews our 
data towards poorer outcomes.
With all the limitations mentioned above, we 
conclude that no specific factor regarding CS could 
be identified as having a significant effect on the 
patient’s outcome. It may be that CS has minimal 
physiological effects on the body. Larger multicentre 
prospective studies should be conducted in this 
area to enlighten the impact of anaesthetics on these 
patients.
CONCLUSION
In our study, good outcome in patients undergoing 
endovascular treatment for AIS under CS is associated 
with higher post-treatment mTICI score, lower NIHSS 
score at presentation and a lack of previous TIA.
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NIHSS score – National Institute of Health Stroke Scale score
mTICI – Modified treatment in cerebral ischaemia score; MCA – Middle 
cerebral artery
Appendix 1
Appendix 2
mRS – Modified Rankin Scale score
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